Genflow Biosciences has initiated a SIRT6 gene therapy trial in 28 senior dogs, aiming to enhance healthspan and quality of life. Much like well-planned clinical studies in humans, this trial explores effective biological aging interventions. Follow the insights shared by CEO Dr Eric Leire on Longevity.Technology for promising developments in pet health.